Patents by Inventor Sharon Busby

Sharon Busby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating autoimmune diseases using a TACI-Ig fusion molecule
    Patent number: 8784812
    Abstract: In various embodiments, the present invention provides methods and compositions for treatment of autoimmune diseases, including rheumatoid arthritis, for example comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule. In one embodiment, the TACI-Ig fusion molecule is administered in amount sufficient to slow, suppress or inhibit proliferation-inducing functions of BlyS and APRIL.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: July 22, 2014
    Assignees: Zymogenetics, Inc., Ares Trading S.A.
    Inventors: Herve Broly, Jennifer Visich, Ivan Nestorov, Sharon Busby, Jane Gross
  • METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-IG FUSION MOLECULE
    Publication number: 20070274984
    Abstract: In various embodiments, the present invention provides methods and compositions for treatment of autoimmune diseases, including rheumatoid arthritis, for example comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule. In one embodiment, the TACI-Ig fusion molecule is administered in amount sufficient to slow, suppress or inhibit proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: May 15, 2007
    Publication date: November 29, 2007
    Applicants: ARES TRADING S.A., ZYMOGENETICS, INC.
    Inventors: Herve Broly, Jennifer Visich, Ivan Nestorov, Sharon Busby, Jane Gross
  • Methods for treating B-cell malignancies using a TACI-Ig fusion molecule
    Publication number: 20070071760
    Abstract: The present invention provides methods and compositions for treatment of B-cell malignancies, including non-Hodgkin's lymphoma, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: August 9, 2006
    Publication date: March 29, 2007
    Inventors: Herve Broly, Arnaud Ythier, Eric Sievers, Sharon Busby, Jan Ohrstrom, Ivan Nestorov, Stephen Ansell